Mometasone Biogaran (Mometasone Furoate Anhydrous)

Mometasone furoate, the active ingredient in Mometasone Biogaran, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation in the nasal passages of patients with allergic rhinitis and nasal polyps, providing symptom relief such as decreased congestion, sneezing, and itching.

GNH USA supplies Mometasone Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this nasal corticosteroid. Products are shipped through regulated supply chains to ensure integrity.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal mucosa.

Allergic rhinitis: relief of nasal congestion, sneezing, itching and runny nose. Nasal polyps: reduction of polyp size and improvement of nasal airflow. Seasonal allergic rhinitis: control of symptoms during pollen exposure.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Headache: transient headache. - Epistaxis: occasional nosebleeds. - Throat irritation: dryness or soreness.

Serious or Rare Side Effects: - Nasal septal perforation: rare tissue damage. - Elevated intraocular pressure: risk of glaucoma. - Adrenal suppression: systemic glucocorticoid effect with prolonged high‑dose use.

Before prescribing Mometasone furoate nasal spray, clinicians should consider several safety precautions.

- Assess infection: avoid use in patients with active nasal or sinus infections without medical supervision. - Monitor ocular health: patients with glaucoma or cataracts should be evaluated regularly. - Evaluate systemic steroid exposure: caution in individuals receiving other glucocorticoids. - Use in pregnancy: prescribe only if benefit outweighs potential risk. - Pediatric use: limit duration and monitor growth in children. - Store below 25°C: keep in the original pack, protect from moisture.

Mometasone furoate nasal spray can interact with other medications, affecting its safety or efficacy.

Major Interactions (Avoid): - CYP3A4 inhibitors: concurrent strong inhibitors (e.g., ketoconazole) may increase systemic exposure. - Systemic glucocorticoids: combined use can enhance risk of adrenal suppression.

Moderate Interactions (Monitor Closely): - Antifungal azoles: may modestly raise mometasone levels. - Antihistamines: additive nasal irritation possible. - Vaccines: live vaccines may have reduced efficacy if systemic absorption occurs.